United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 373.785 USD 3.43% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

United Therapeutics Corp
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Therapeutics Corp
Long-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
United Therapeutics Corp
NASDAQ:UTHR
Long-Term Investments
$1.3B
CAGR 3-Years
0%
CAGR 5-Years
26%
CAGR 10-Years
17%
Abbvie Inc
NYSE:ABBV
Long-Term Investments
$272m
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Investments
$376m
CAGR 3-Years
-23%
CAGR 5-Years
-34%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Investments
$4.5B
CAGR 3-Years
497%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Investments
$7.7B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
30%

See Also

What is United Therapeutics Corp's Long-Term Investments?
Long-Term Investments
1.3B USD

Based on the financial report for Jun 30, 2024, United Therapeutics Corp's Long-Term Investments amounts to 1.3B USD.

What is United Therapeutics Corp's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
17%

Over the last year, the Long-Term Investments growth was -34%.

Back to Top